| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $45.9B | — | — | — | — |
| Op. Income | $8.8B | — | — | — | — |
| Gross Margin | 36.8% | — | — | — | — |
| Net Margin | 19.0% | — | — | — | — |
| EPS (Diluted) | $8.16 | — | — | — | — |
| Free Cash Flow | $7.3B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $45.9B |
| Cost of Revenue | $29.0B |
| GROSS PROFIT | $16.9B |
| R&D Expenses | $1.6B |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $4.1B |
| Other Expenses | $2.4B |
| Operating Expenses | $8.1B |
| Cost & Expenses | $37.1B |
| OPERATING INCOME | $8.8B |
| Interest Income | $0 |
| Interest Expense | $843M |
| Other Income/Expenses | $1.2B |
| INCOME BEFORE TAX | $10.0B |
| Income Tax Expense | $1.4B |
| Net Income from Continuing Ops | $8.6B |
| Net Income from Discontinued Ops | $103M |
| Other Adjustments | $0 |
| NET INCOME | $8.7B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8.7B |
| D&A | $1.2B |
| EBIT | $10.8B |
| EBITDA | $12.1B |
| EPS | $8 |
| EPS Diluted | $8 |
| Item | Amount |
|---|---|
| REVENUE | $45.9B |
| Cost of Revenue | $29.0B |
| GROSS PROFIT | $16.9B |
| R&D Expenses | $1.6B |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $4.1B |
| Other Expenses | $2.4B |
| Operating Expenses | $8.1B |
| Cost & Expenses | $37.1B |
| OPERATING INCOME | $8.8B |
| Interest Income | $0 |
| Interest Expense | $843M |
| Other Income/Expenses | $1.2B |
| INCOME BEFORE TAX | $10.0B |
| Income Tax Expense | $1.4B |
| Net Income from Continuing Ops | $8.6B |
| Net Income from Discontinued Ops | $103M |
| Other Adjustments | $0 |
| NET INCOME | $8.7B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $8.7B |
| D&A | $1.2B |
| EBIT | $10.8B |
| EBITDA | $12.1B |
| EPS | $8 |
| EPS Diluted | $8 |
| Item | Amount |
|---|---|
| Net Income | $8.7B |
| Depreciation & Amortization | $1.2B |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$911M |
| Change in Working Capital | -$470M |
| OPERATING CASH FLOW | $8.5B |
| Capital Expenditure | -$1.3B |
| Acquisitions (Net) | -$360M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $480M |
| NET CASH FROM INVESTING | -$1.2B |
| Net Debt Issuance | $199M |
| Common Stock Repurchased | -$7.6B |
| Common Dividends Paid | -$1.5B |
| Other Financing Activities | $120M |
| NET CASH FROM FINANCING | -$8.7B |
| FREE CASH FLOW | $7.3B |
| Net Change in Cash | -$1.1B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $12.4B |
| Short-Term Investments | $0 |
| Net Receivables | $15.3B |
| Inventory | $11.9B |
| Other Current Assets | $1.1B |
| TOTAL CURRENT ASSETS | $40.6B |
| PP&E (Net) | $8.0B |
| Goodwill | $9.1B |
| Intangible Assets | $4.2B |
| Long-Term Investments | $38.8B |
| Tax Assets | $7.5B |
| Other Non-Current Assets | $22.1B |
| TOTAL NON-CURRENT ASSETS | $89.6B |
| TOTAL ASSETS | $130.2B |
| Account Payables | $10.1B |
| Short-Term Debt | $1.7B |
| Deferred Revenue | $18.0B |
| Other Current Liabilities | $9.2B |
| TOTAL CURRENT LIABILITIES | $39.0B |
| Long-Term Debt | $18.8B |
| Deferred Revenue NC | $1.1B |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $52.4B |
| TOTAL NON-CURRENT LIABILITIES | $72.3B |
| TOTAL LIABILITIES | $111.3B |
| Common Stock | $15M |
| Additional Paid-In Capital | $23.6B |
| Retained Earnings | $87.7B |
| Treasury Stock | -$87.8B |
| Accum. Other Comp. Income | -$4.8B |
| Other Equity | -$1M |
| TOTAL STOCKHOLDERS' EQUITY | $18.7B |
| Minority Interest | $221M |
| TOTAL EQUITY | $18.9B |
| TOTAL LIABILITIES & EQUITY | $130.2B |
| Total Debt | $20.5B |
| Net Debt | $8.1B |
